Beirut, October 12th, 2022 - HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and Center (KHCC), inaugurated the Pediatric Cancer Department and Al Makassed Cultural Forum at Al Makassed General Hospital (part of Al Makassed Philanthropic Islamic Association of Beirut).
Amman, October 5th, 2022 â HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and Center (KHCC), launched the 7th Arab Breast Cancer Awareness Campaign with the slogan âAn image for life...get tested.â The campaign aims to spread awareness on the importance of early breast cancer detection and encourage women to perform annual examinations.
Amman, August 8th, 2022 - HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and Center (KHCC) inaugurated KHCCâs Healing Garden, which will serve as a unique outdoor space that will enhance patientsâ treatment experience, and offer feelings of calm and reassurance for patients and their families. Â
ÙAmman, June 8th,2022 His Majesty King Abdullah on Wednesday attended a celebration marking the 20th anniversary of the King Hussein Cancer Foundation and Centre (KHCC), ranked sixth in the world as a specialised cancer treatment centre.
Amman, 30 May 2022Â â HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and Center (KHCC), graduated 100 students from KHCFâs âBack-to-Schoolâ program. The program enabled its students, who are currently patients undergoing treatment at KHCC, to finish the 2021-2022 school year without interruption, despite the challenges of their medical condition.
Amman, 26th May, 2022 â Â HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and Center (KHCC) signed a strategic partnership agreement with the pharmaceutical company AstraZeneca, which was represented by Dr. Pelin Incesu, the vice president of its regional office for the Middle East and Africa. In line with the agreement, AstraZeneca will support KHCFâs endeavors toward fighting cancer in Jordan in multiple areas for the next 3 years.